Drug development
The development of biotechnologically produced drugs has made it possible to treat diseases at their cause, to do this more efficiently and with fewer side effects, or even to cure diseases. This is the focus of five biotechnology companies on Campus Berlin-Buch.
The spectrum of their drug development includes highly specific cancer antibodies (Glycotope GmbH), novel treatments targeting the cause of heart failure (Berlin Cures GmbH) or atrial fibrillation (OMEICOS Therapeutics GmbH), extremely effective antibiotics (MerLion Pharmaceuticals) and RNAi-based therapeutics for systemic cancers that can selectively regulate disease-related genes (Silence Therapeutics). Here, T-Knife, a spin-off from the Charité and the Max Delbrück Center, is developing one of the first T cell receptor gene therapies in Germany.
News innovation
Eckert & Ziegler opens new facilities for radiopharmaceutical plant engineering in Dresden
In the presence of the Saxon State Ministers Martin Dulig and Thomas Schmidt as well as the Mayor of Dresden Dirk Hilbert, the medical technology company Eckert & Ziegler today inaugurated its new 1,7...
more ...Eckert & Ziegler becomes European contract manufacturer for Telix's innovative Phase III ProstACT GLOBAL study
Eckert & Ziegler and Telix Pharmaceuticals Limited (Telix) today announced the signing of a significant multi-year agreement under which Eckert & Ziegler will serve as the European contract manufactur...
more ...Eckert & Ziegler extends GalliaPharm® availability to the entire European Economic Area
Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler) has received approval from the European Commission (EC) for its Ge-68/Ga-68 radionuclide generator GalliaPharm®.
more ...Events Campus
12.09.2024, 09:00
Realtime PCR und digital PCR Kurs
Der RealTime PCR und Digital PCR Kurs richtet sich an erfahrene PCR Anwender*innen und an Einsteiger*innen. Wichtige PCR Grundlagen werden erörtert, bevor die RealTime PCR besprochen und Genexpression...
more ...19.09.2024, 17:00
MDC Freundeskreis: Einladung zu "Musik trifft Wissenschaft" mit Pianist Ron Maxim Huan und Dr. Theda Bartholomäus
Werke von Beethoven, Brahms und Liszt und ein Vortrag „Wer hat das Sagen in uns? Die unsichtbare Macht der Mikroben in unserem Körper“
more ...19.09.2024, 17:00
Talk im Cube: Panel Discussion "Should I Stay or Should I Go? Development Strategies for Life Science Start-Ups"
Continue to grow independently or merge with a larger company? In the highly competitive life science industry start-up companies often face during their development this important strategic decision....
more ...
